Current position:Home >Product >
1-[3-(10-butylphenothiazin-3-yl)-5-cyclopentyl-3,4-dihydropyrazol-2-yl]ethanone; cyclopentane; iron(2+)
1-[3-(10-butylphenothiazin-3-yl)-5-cyclopentyl-3,4-dihydropyrazol-2-yl]ethanone; cyclopentane; iron(2+)
|
|
Canonical SMILES:
CCCCN1C2=C(C=C(C=C2)C3CC(=NN3C(=O)C)[C]4[CH][CH][CH][CH]4)SC5=CC=CC=C51.[CH]1[CH][CH][CH][CH]1.[Fe+2]
Isomeric SMILES
CCCCN1C2=C(C=C(C=C2)C3CC(=NN3C(=O)C)[C]4[CH][CH][CH][CH]4)SC5=CC=CC=C51.[CH]1[CH][CH][CH][CH]1.[Fe+2]
InChI
InChI=1S/C26H26N3OS.C5H5.Fe/c1-3-4-15-28-22-11-7-8-12-25(22)31-26-16-20(13-14-23(26)28)24-17-21(19-9-5-6-10-19)27-29(24)18(2)30;1-2-4-5-3-1;/h5-14,16,24H,3-4,15,17H2,1-2H3;1-5H;/q;;+2
Other Product
- 2,5-bis(chloranyl)cyclohexa-2,5-diene-1,4-diol
- 2,5-bis(chloranyl)benzene-1,4-diol
- 2,5-bis(chloranyl)phenol
- 2-oxidanylidenehexanedioic acid
- 2-oxidanylidene-3-sulfanyl-propanoic acid
- 3-oxidanylbenzaldehyde
- 3-azanylpropanal
- 2-azanyl-3-oxidanyl-benzoic acid
- 3-(3-hydroxyphenyl)propanoic acid
- 3-oxidanylidenehexanedioic acid
- 1-[(1R,2R,5S)-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-2-bicyclo[3.1.0]hex-3-enyl]-5-methyl-pyrimidine-2,4-dione
- [(2R,3R,4R,5R)-5-[7-methyl-2-(2-methylpropanoylamino)-6-oxidanylidene-3H-purin-9-ium-9-yl]-3,4-bis(2-methylpropanoyloxy)oxolan-2-yl]methyl 2-methylpropanoate iodide
- 3-(2-methylprop-1-enyl)cyclohex-2-en-1-one
- (1R,4R,5R)-5-methyl-4-prop-1-en-2-yl-6-oxabicyclo[3.1.0]hexan-4-ol
- (2S,3R)-2-methyl-3-oxidanyl-2-prop-1-en-2-yl-cyclopentan-1-one
- 2-bromanyl-5-[[(4S)-4-[(4-hydroxyphenyl)methyl]-1,3-oxazolidin-3-yl]methyl]benzene-1,3-diol
- 2-bromanyl-5-[[(4S)-4-[(4-hydroxyphenyl)methyl]-2,2-dimethyl-1,3-oxazolidin-3-yl]methyl]benzene-1,3-diol
- (3aS)-7-bromanyl-6,8-bis(prop-2-enoxy)spiro[3,3a,4,10-tetrahydro-[1,3]oxazolo[3,4-b][2]benzazepine-5,4'-cyclohexa-2,5-diene]-1,1'-dione
- 5-(7-bromanyl-3-phenyl-2H-1-benzofuran-3-yl)-4-[5-(4-iodanyl-1H-indol-3-yl)-1,3-oxazol-2-yl]-2-methyl-1,3-oxazole
- 2-[(1S)-1-azanyl-2-methyl-propyl]-5-[(E)-1-(2-phenylmethoxyphenyl)prop-1-enyl]-1,3-oxazole-4-carbonitrile

